Connection

Brent Egan to Humans

This is a "connection" page, showing publications Brent Egan has written about Humans.
Connection Strength

2.800
  1. Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions. Blood Press. 2022 12; 31(1):164-168.
    View in: PubMed
    Score: 0.033
  2. Association of Baseline Adherence to Antihypertensive Medications With Adherence After Shelter-in-Place Guidance for COVID-19 Among US Adults. JAMA Netw Open. 2022 12 01; 5(12):e2247787.
    View in: PubMed
    Score: 0.033
  3. Hypertension Control Among US Adults, 2009 to 2012 Through 2017 to 2020, and the Impact of COVID-19. Hypertension. 2022 09; 79(9):1981-1983.
    View in: PubMed
    Score: 0.032
  4. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines. Hypertension. 2022 02; 79(2):338-348.
    View in: PubMed
    Score: 0.031
  5. Editorial commentary: Racial and Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018. Hypertension. 2021 12; 78(6):1727-1729.
    View in: PubMed
    Score: 0.031
  6. Baseline Heart Rate Predicts the Blood Pressure Response to Renal Denervation in Untreated Hypertension. J Am Coll Cardiol. 2021 09 07; 78(10):1039-1041.
    View in: PubMed
    Score: 0.030
  7. Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups. Hypertension. 2021 09; 78(3):578-587.
    View in: PubMed
    Score: 0.030
  8. Editorial commentary on 'Country of birth and mortality risk in hypertension with and without diabetes: the Swedish Primary Care Cardiovascular Database'. J Hypertens. 2021 06 01; 39(6):1104-1106.
    View in: PubMed
    Score: 0.030
  9. Sociodemographic Determinants of Life's Simple 7: Implications for Achieving Cardiovascular Health and Health Equity Goals. Ethn Dis. 2020; 30(4):637-650.
    View in: PubMed
    Score: 0.028
  10. Antihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database. Hypertension. 2020 08; 76(2):330-332.
    View in: PubMed
    Score: 0.028
  11. Hypertension in military veterans is associated with combat exposure and combat injury. J Hypertens. 2020 07; 38(7):1255-1256.
    View in: PubMed
    Score: 0.028
  12. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367.
    View in: PubMed
    Score: 0.027
  13. Habitual protein intake, protein distribution patterns and dietary sources in Irish adults with stratification by sex and age. J Hum Nutr Diet. 2020 08; 33(4):465-476.
    View in: PubMed
    Score: 0.027
  14. The prevalence of concurrently raised blood glucose and blood pressure in India. J Hypertens. 2019 09; 37(9):1788-1789.
    View in: PubMed
    Score: 0.026
  15. Optimal Systolic Blood Pressure Target in Resistant Hypertension. Am J Med. 2019 07; 132(7):e623.
    View in: PubMed
    Score: 0.026
  16. A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions. PLoS One. 2019; 14(6):e0217696.
    View in: PubMed
    Score: 0.026
  17. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019 06; 37(6):1148-1153.
    View in: PubMed
    Score: 0.026
  18. Adherence in Hypertension. Circ Res. 2019 03 29; 124(7):1124-1140.
    View in: PubMed
    Score: 0.025
  19. Implementation of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Hypertension. 2019 02; 73(2):288-290.
    View in: PubMed
    Score: 0.025
  20. Prognostic value of blood pressure control delay in newly diagnosed hypertensive patients. J Hypertens. 2019 02; 37(2):290-291.
    View in: PubMed
    Score: 0.025
  21. Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol. Hypertension. 2018 12; 72(6):1320-1327.
    View in: PubMed
    Score: 0.025
  22. Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment. Hypertension. 2018 11; 72(5):1090-1092.
    View in: PubMed
    Score: 0.025
  23. Insights on ?-blockers for the treatment of hypertension: A survey of health care practitioners. J Clin Hypertens (Greenwich). 2018 10; 20(10):1464-1472.
    View in: PubMed
    Score: 0.025
  24. Defining Hypertension by Blood Pressure 130/80 mm Hg Leads to an Impressive Burden of Hypertension in Young and Middle-Aged Black Adults: Follow-Up in the CARDIA Study. J Am Heart Assoc. 2018 07 14; 7(14).
    View in: PubMed
    Score: 0.024
  25. Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States. J Clin Hypertens (Greenwich). 2018 06; 20(6):991-1000.
    View in: PubMed
    Score: 0.024
  26. Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. J Clin Hypertens (Greenwich). 2018 01; 20(1):79-87.
    View in: PubMed
    Score: 0.023
  27. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial. J Prev Alzheimers Dis. 2018; 5(3):175-183.
    View in: PubMed
    Score: 0.023
  28. Cholesterol Control Among Uninsured Adults Did Not Improve From 2001-2004 to 2009-2012 as Disparities With Both Publicly and Privately Insured Adults Doubled. J Am Heart Assoc. 2017 Nov 02; 6(11).
    View in: PubMed
    Score: 0.023
  29. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017 08; 70(2):275-284.
    View in: PubMed
    Score: 0.023
  30. Opportunities for improving cardiovascular health outcomes in adults younger than 65?years with guideline-recommended statin therapy. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):850-860.
    View in: PubMed
    Score: 0.022
  31. Physical Activity and Hypertension: Knowing Is Not Enough; We Must Apply. Willing Is Not Enough; We Must Do-von Goethe. Hypertension. 2017 03; 69(3):404-406.
    View in: PubMed
    Score: 0.022
  32. Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2017 Mar; 19(3):241-249.
    View in: PubMed
    Score: 0.022
  33. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals. J Am Heart Assoc. 2016 08 19; 5(8).
    View in: PubMed
    Score: 0.021
  34. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension. 2016 08; 68(2):318-23.
    View in: PubMed
    Score: 0.021
  35. Aldosterone Antagonists or Renin-Guided Therapy for Treatment-Resistant Hypertension: A Comparative Effectiveness Pilot Study in Primary Care. Am J Hypertens. 2016 08; 29(8):976-83.
    View in: PubMed
    Score: 0.021
  36. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2016 08; 18(8):817-24.
    View in: PubMed
    Score: 0.021
  37. Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):56-66.
    View in: PubMed
    Score: 0.020
  38. Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry. J Clin Hypertens (Greenwich). 2016 07; 18(7):663-71.
    View in: PubMed
    Score: 0.020
  39. Treatment Resistant Hypertension. Ethn Dis. 2015 Nov 05; 25(4):495-8.
    View in: PubMed
    Score: 0.020
  40. Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences. Ethn Dis. 2015 Nov 05; 25(4):511-4.
    View in: PubMed
    Score: 0.020
  41. The importance of masked hypertension in adults with prehypertension. Nat Rev Cardiol. 2015 Aug; 12(8):497.
    View in: PubMed
    Score: 0.020
  42. Elijah Saunders in Memoriam. J Clin Hypertens (Greenwich). 2015 Jun; 17(6):415-7.
    View in: PubMed
    Score: 0.020
  43. Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich). 2015 Apr; 17(4):252-9.
    View in: PubMed
    Score: 0.019
  44. Prehypertension--prevalence, health risks, and management strategies. Nat Rev Cardiol. 2015 May; 12(5):289-300.
    View in: PubMed
    Score: 0.019
  45. Effectiveness of a tailored behavioral intervention to improve hypertension control. Hypertension. 2015 Feb; 65(2):273-5.
    View in: PubMed
    Score: 0.019
  46. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014 Nov 04; 130(19):1692-9.
    View in: PubMed
    Score: 0.019
  47. The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004.
    View in: PubMed
    Score: 0.019
  48. Opportunities for multidisciplinary ASH clinical hypertension specialists in an era of population health and accountable care: ASH leadership message. J Am Soc Hypertens. 2014 Jul; 8(7):451-6.
    View in: PubMed
    Score: 0.018
  49. Diabetes and age-related demographic differences in risk factor control. J Am Soc Hypertens. 2014 Jun; 8(6):394-404.
    View in: PubMed
    Score: 0.018
  50. Role of aldosterone blockade in resistant hypertension. Semin Nephrol. 2014 May; 34(3):273-84.
    View in: PubMed
    Score: 0.018
  51. Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
    View in: PubMed
    Score: 0.018
  52. Formation of community-based hypertension practice networks: success, obstacles, and lessons learned. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):393-7.
    View in: PubMed
    Score: 0.018
  53. Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity. Hypertension. 2014 Mar; 63(3):e17-8.
    View in: PubMed
    Score: 0.018
  54. Pre-hypertension: rationale for pharmacotherapy. Curr Hypertens Rep. 2013 Dec; 15(6):669-75.
    View in: PubMed
    Score: 0.018
  55. Prediction of incident hypertension. Health implications of data mining in the 'Big Data' era. J Hypertens. 2013 Nov; 31(11):2123-4.
    View in: PubMed
    Score: 0.018
  56. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013 Oct; 62(4):691-7.
    View in: PubMed
    Score: 0.017
  57. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013 Jul 02; 128(1):29-41.
    View in: PubMed
    Score: 0.017
  58. Plasma lipidomic profile signature of hypertension in mexican american families. Hypertension. 2013 Sep; 62(3):453-4.
    View in: PubMed
    Score: 0.017
  59. Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial. Soc Sci Med. 2013 Jun; 87:108-15.
    View in: PubMed
    Score: 0.017
  60. Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J Hypertens. 2013 Feb; 31(2):259-60.
    View in: PubMed
    Score: 0.017
  61. Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):95-101.
    View in: PubMed
    Score: 0.017
  62. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):154-61.
    View in: PubMed
    Score: 0.017
  63. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):751-9.
    View in: PubMed
    Score: 0.016
  64. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health. Hypertension. 2012 Oct; 60(4):891-3.
    View in: PubMed
    Score: 0.016
  65. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012 Jun; 59(6):1124-31.
    View in: PubMed
    Score: 0.016
  66. Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice. Ethn Dis. 2012; 22(1):29-37.
    View in: PubMed
    Score: 0.015
  67. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87.
    View in: PubMed
    Score: 0.015
  68. Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea. Hypertension. 2011 Oct; 58(4):542-3.
    View in: PubMed
    Score: 0.015
  69. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
    View in: PubMed
    Score: 0.015
  70. Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011 Aug; 13(8):543-50.
    View in: PubMed
    Score: 0.015
  71. Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011 Jul; 26(4):300-7.
    View in: PubMed
    Score: 0.015
  72. Overnight rostral fluid shift and obstructive sleep apnea in treatment resistant hypertension: connecting the dots clarifies the picture. Hypertension. 2010 Dec; 56(6):1040-1.
    View in: PubMed
    Score: 0.014
  73. Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010 Nov; 28(4):561-9.
    View in: PubMed
    Score: 0.014
  74. Prevalence and management of hypertension in the inpatient setting: a systematic review. J Hosp Med. 2011 Sep; 6(7):417-22.
    View in: PubMed
    Score: 0.014
  75. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26; 303(20):2043-50.
    View in: PubMed
    Score: 0.014
  76. Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension. 2010 Jun; 55(6):1289-95.
    View in: PubMed
    Score: 0.014
  77. Antihypertensive medication prescribing patterns in a university teaching hospital. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):246-52.
    View in: PubMed
    Score: 0.014
  78. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010 Apr; 24(4):237-46.
    View in: PubMed
    Score: 0.013
  79. Pleiotropic benefits of moderate salt reduction. Hypertension. 2009 Sep; 54(3):447-8.
    View in: PubMed
    Score: 0.013
  80. Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens. 2009 Dec; 23(12):826-35.
    View in: PubMed
    Score: 0.013
  81. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801.
    View in: PubMed
    Score: 0.013
  82. Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle. Hypertension. 2009 Apr; 53(4):598-9.
    View in: PubMed
    Score: 0.013
  83. Sleep-disordered breathing and blood pressure in children. Hypertension. 2008 Nov; 52(5):807.
    View in: PubMed
    Score: 0.012
  84. Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008 Oct; 10(5):359-66.
    View in: PubMed
    Score: 0.012
  85. Sodium intake and mortality: the debate continues. J Gen Intern Med. 2008 Sep; 23(9):1537-8.
    View in: PubMed
    Score: 0.012
  86. Dietary management in the prevention and treatment of hypertension: does it work? J Clin Hypertens (Greenwich). 2008 Aug; 10(8):632-9.
    View in: PubMed
    Score: 0.012
  87. Prehypertension: should we be treating with pharmacologic therapy? Ther Adv Cardiovasc Dis. 2008 Aug; 2(4):305-14.
    View in: PubMed
    Score: 0.012
  88. Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker. J Clin Hypertens (Greenwich). 2007 Oct; 9(10):783-9.
    View in: PubMed
    Score: 0.011
  89. Dietary salt restriction and blood pressure in clinical trials. Curr Hypertens Rep. 2007 Aug; 9(4):314-9.
    View in: PubMed
    Score: 0.011
  90. From TROPHY with pride. Am J Hypertens. 2007 Mar; 20(3):342-3; author reply 343-5.
    View in: PubMed
    Score: 0.011
  91. Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women. Ethn Dis. 2007; 17(4):617-23.
    View in: PubMed
    Score: 0.011
  92. Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86.
    View in: PubMed
    Score: 0.011
  93. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic. Arq Bras Cardiol. 2006 Oct; 87(4):538-47.
    View in: PubMed
    Score: 0.011
  94. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension. J Hypertens. 2006 Jul; 24(7):1383-9.
    View in: PubMed
    Score: 0.011
  95. Sleep and hypertension: burning the candle at both ends really is hazardous to your health. Hypertension. 2006 May; 47(5):816-7.
    View in: PubMed
    Score: 0.010
  96. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006 Mar; 47(3):345-51.
    View in: PubMed
    Score: 0.010
  97. Challenges and risks in attaining the systolic blood pressure goal of <130 mm Hg in all diabetic patients. J Clin Hypertens (Greenwich). 2006 Jan; 8(1):50-2.
    View in: PubMed
    Score: 0.010
  98. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich). 2005 Dec; 7(12):705-11; quiz 712-3.
    View in: PubMed
    Score: 0.010
  99. Ethnic differences in the treatment and control of hypertension in patients with diabetes. J Clin Hypertens (Greenwich). 2005 Aug; 7(8):445-54.
    View in: PubMed
    Score: 0.010
  100. Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients. Am J Hypertens. 2005 Aug; 18(8):1026-32.
    View in: PubMed
    Score: 0.010
  101. Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):386-94.
    View in: PubMed
    Score: 0.010
  102. Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):409-16.
    View in: PubMed
    Score: 0.010
  103. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005 Jul-Aug; 3(4):294-9.
    View in: PubMed
    Score: 0.010
  104. Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension. Am J Hypertens. 2005 Jul; 18(7):972-9.
    View in: PubMed
    Score: 0.010
  105. Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med. 2005 May 09; 165(9):1041-7.
    View in: PubMed
    Score: 0.010
  106. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12.
    View in: PubMed
    Score: 0.010
  107. Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis. 2005; 15(1):11-6.
    View in: PubMed
    Score: 0.010
  108. Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis. 2005; 15(1):25-32.
    View in: PubMed
    Score: 0.010
  109. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol. 2004 Dec 15; 94(12):1496-500.
    View in: PubMed
    Score: 0.009
  110. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL. Curr Med Res Opin. 2004 Dec; 20(12):1909-17.
    View in: PubMed
    Score: 0.009
  111. A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004 Oct; 97(10):932-8.
    View in: PubMed
    Score: 0.009
  112. Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease. Am J Kidney Dis. 2004 Sep; 44(3):446-54.
    View in: PubMed
    Score: 0.009
  113. Hypertension in the 21st century: the tide is rising; our daze must end. Hypertension. 2004 Oct; 44(4):389.
    View in: PubMed
    Score: 0.009
  114. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
    View in: PubMed
    Score: 0.009
  115. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
    View in: PubMed
    Score: 0.009
  116. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3.
    View in: PubMed
    Score: 0.009
  117. TIME to face the reality about evening dosing of antihypertensive drugs in hypertension. Blood Press. 2023 Dec; 32(1):1-3.
    View in: PubMed
    Score: 0.009
  118. Beta-blockers for cardioprotection. A forgotten message? Postgrad Med. 2003 Dec; 114(6 Suppl Role):3.
    View in: PubMed
    Score: 0.009
  119. The role of sympathetic activation in cardiovascular disease. Postgrad Med. 2003 Dec; 114(6 Suppl Role):4-10.
    View in: PubMed
    Score: 0.009
  120. Other important applications for beta-blockers in high-risk patients. Postgrad Med. 2003 Dec; 114(6 Suppl Role):35-48.
    View in: PubMed
    Score: 0.009
  121. Cardiovascular risk factor control and treatment patterns in primary care. Manag Care Interface. 2003 Nov; 16(11):21-6.
    View in: PubMed
    Score: 0.009
  122. Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report? J Investig Med. 2003 Nov; 51(6):373-85.
    View in: PubMed
    Score: 0.009
  123. Reproducibility of BP responses to changes in dietary salt: compelling evidence for universal sodium restriction? Hypertension. 2003 Oct; 42(4):457-8.
    View in: PubMed
    Score: 0.009
  124. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep. 2003 Jun; 5(3):247-54.
    View in: PubMed
    Score: 0.009
  125. 2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health. J S C Med Assoc. 2003 Jun; 99(6):157-61.
    View in: PubMed
    Score: 0.009
  126. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003 Mar 24; 163(6):681-7.
    View in: PubMed
    Score: 0.008
  127. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003 Mar; 41(3):422-30.
    View in: PubMed
    Score: 0.008
  128. Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects. Am J Hypertens. 2003 Jan; 16(1):67-71.
    View in: PubMed
    Score: 0.008
  129. Hypertension management during the COVID-19 pandemic: what can we learn for the future? Blood Press. 2022 12; 31(1):47-49.
    View in: PubMed
    Score: 0.008
  130. Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy. Blood Press. 2022 12; 31(1):125-128.
    View in: PubMed
    Score: 0.008
  131. Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure. Blood Press. 2022 12; 31(1):207-209.
    View in: PubMed
    Score: 0.008
  132. Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke. J Neurol Sci. 2022 10 15; 441:120334.
    View in: PubMed
    Score: 0.008
  133. Ethnicity and unprovoked hypokalemia in the ARIC Study. Am J Hypertens. 2002 Jul; 15(7 Pt 1):660-1.
    View in: PubMed
    Score: 0.008
  134. Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013-2018. Am J Hypertens. 2022 Jun 16; 35(6):514-525.
    View in: PubMed
    Score: 0.008
  135. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002 Jun; 20(6):1215-21.
    View in: PubMed
    Score: 0.008
  136. American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002 Apr; 15(4 Pt 1):372-9.
    View in: PubMed
    Score: 0.008
  137. Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension. Am J Hypertens. 2022 03 08; 35(3):232-243.
    View in: PubMed
    Score: 0.008
  138. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022 01; 79(1):e1-e14.
    View in: PubMed
    Score: 0.008
  139. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
    View in: PubMed
    Score: 0.008
  140. The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. Am J Hypertens. 2001 Oct; 14(10):1032-7.
    View in: PubMed
    Score: 0.008
  141. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2021 11; 78(5):e38-e50.
    View in: PubMed
    Score: 0.008
  142. Hemodynamic effects of lipids in humans. Am J Physiol Regul Integr Comp Physiol. 2001 Jun; 280(6):R1674-9.
    View in: PubMed
    Score: 0.007
  143. Insulin resistance and cardiovascular disease. Am J Hypertens. 2001 Jun; 14(6 Pt 2):116S-125S.
    View in: PubMed
    Score: 0.007
  144. Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep. 2001 Apr; 3(2):107-16.
    View in: PubMed
    Score: 0.007
  145. The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. J S C Med Assoc. 2001 Feb; 97(2):57-62.
    View in: PubMed
    Score: 0.007
  146. Acute physical and mental stress resulted in an increase in fatty acids, norepinephrine, and hemodynamic changes in normal individuals: A possible pathophysiological mechanism for hypertension-Pilot study. J Clin Hypertens (Greenwich). 2021 04; 23(4):888-894.
    View in: PubMed
    Score: 0.007
  147. Efficacy of a church-based intervention on cardiovascular risk reduction. Ethn Dis. 2001; 11(4):817-22.
    View in: PubMed
    Score: 0.007
  148. Biochemical and metabolic effects of very-low-salt diets. Am J Med Sci. 2000 Oct; 320(4):233-9.
    View in: PubMed
    Score: 0.007
  149. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis. Ir J Med Sci. 2020 Aug; 189(3):1023-1026.
    View in: PubMed
    Score: 0.007
  150. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23.
    View in: PubMed
    Score: 0.007
  151. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci. 1999 Dec; 318(6):365-8.
    View in: PubMed
    Score: 0.007
  152. Relationship between 'on-treatment platelet reactivity', shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis. J Neurol. 2020 Jan; 267(1):168-184.
    View in: PubMed
    Score: 0.007
  153. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):411-20.
    View in: PubMed
    Score: 0.006
  154. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018 11; 72(5):e53-e90.
    View in: PubMed
    Score: 0.006
  155. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension. 1998 Oct; 32(4):693-8.
    View in: PubMed
    Score: 0.006
  156. Nicotine replacement therapy sampling via primary care: Methods from a pragmatic cluster randomized clinical trial. Contemp Clin Trials. 2018 09; 72:1-7.
    View in: PubMed
    Score: 0.006
  157. Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism. Hypertension. 1997 Dec; 30(6):1634-9.
    View in: PubMed
    Score: 0.006
  158. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension. 1997 Nov; 30(5):1150-5.
    View in: PubMed
    Score: 0.006
  159. Nonesterified fatty acids in the pathogenesis of hypertension: theory and evidence. Prostaglandins Leukot Essent Fatty Acids. 1997 Jul; 57(1):57-63.
    View in: PubMed
    Score: 0.006
  160. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. J Neurol Sci. 2017 Apr 15; 375:404-410.
    View in: PubMed
    Score: 0.006
  161. Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering. Am J Clin Nutr. 1997 02; 65(2 Suppl):671S-677S.
    View in: PubMed
    Score: 0.005
  162. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385.
    View in: PubMed
    Score: 0.005
  163. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996 Aug; 28(2):228-37.
    View in: PubMed
    Score: 0.005
  164. Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am J Physiol. 1996 Jun; 270(6 Pt 2):R1340-6.
    View in: PubMed
    Score: 0.005
  165. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents. J Clin Hypertens (Greenwich). 2016 09; 18(9):942-8.
    View in: PubMed
    Score: 0.005
  166. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996 Mar; 27(3 Pt 2):723-8.
    View in: PubMed
    Score: 0.005
  167. Orthopaedic complications following cardiac transplantation. Ir Med J. 1996 Jan-Feb; 89(1):26-7.
    View in: PubMed
    Score: 0.005
  168. Social and Medical Determinants of Cardiometabolic Health: The Big Picture. Ethn Dis. 2015 Nov 05; 25(4):521-4.
    View in: PubMed
    Score: 0.005
  169. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995 Nov; 26(5):764-70.
    View in: PubMed
    Score: 0.005
  170. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol. 2015 Sep 01; 66(9):1050-67.
    View in: PubMed
    Score: 0.005
  171. The Results of the "Positive Action for Today's Health" (PATH) Trial for Increasing Walking and Physical Activity in Underserved African-American Communities. Ann Behav Med. 2015 Jun; 49(3):398-410.
    View in: PubMed
    Score: 0.005
  172. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995 Apr; 25(4 Pt 2):774-8.
    View in: PubMed
    Score: 0.005
  173. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):235-43.
    View in: PubMed
    Score: 0.005
  174. Chaos to complexity: leveling the playing field for measuring value in primary care. J Eval Clin Pract. 2017 Apr; 23(2):430-438.
    View in: PubMed
    Score: 0.005
  175. Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995 Feb; 268(2 Pt 2):R562-8.
    View in: PubMed
    Score: 0.005
  176. Is there a role for dietary fish oil in the treatment of hypertension? J Hum Hypertens. 1994 Dec; 8(12):895-905.
    View in: PubMed
    Score: 0.005
  177. Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74.
    View in: PubMed
    Score: 0.005
  178. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994 Oct; 7(10 Pt 1):886-93.
    View in: PubMed
    Score: 0.005
  179. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J Hypertens. 1994 Sep; 12(9):1061-7.
    View in: PubMed
    Score: 0.005
  180. Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night. Am J Hypertens. 1994 Jul; 7(7 Pt 1):609-14.
    View in: PubMed
    Score: 0.005
  181. Increasing capacity for quality improvement in underresourced primary care settings. Qual Manag Health Care. 2014 Jul-Sep; 23(3):155-62.
    View in: PubMed
    Score: 0.005
  182. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12.
    View in: PubMed
    Score: 0.005
  183. The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
    View in: PubMed
    Score: 0.004
  184. In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension. J Hypertens. 2014 Feb; 32(2):251-9.
    View in: PubMed
    Score: 0.004
  185. Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects. J Hum Hypertens. 1994 Jan; 8(1):59-64.
    View in: PubMed
    Score: 0.004
  186. Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension. 1994 Jan; 23(1 Suppl):I1-7.
    View in: PubMed
    Score: 0.004
  187. Decreased heart rate variability is associated with increased transcranial Doppler velocities in children with sickle cell disease. Ethn Dis. 2014; 24(4):451-5.
    View in: PubMed
    Score: 0.004
  188. The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo). 2013 Dec; 68(12):1495-501.
    View in: PubMed
    Score: 0.004
  189. Views of parents in four European countries about the effect of food on the mental performance of primary school children. Eur J Clin Nutr. 2014 Jan; 68(1):32-7.
    View in: PubMed
    Score: 0.004
  190. Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):47-53.
    View in: PubMed
    Score: 0.004
  191. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens. 1993 Oct; 11(10):1113-20.
    View in: PubMed
    Score: 0.004
  192. Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993 Oct; 22(4):584-90.
    View in: PubMed
    Score: 0.004
  193. Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22.
    View in: PubMed
    Score: 0.004
  194. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol. 1993 Jul 01; 72(1):53-7.
    View in: PubMed
    Score: 0.004
  195. Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost. 2013 Jul; 11(7):1407-16.
    View in: PubMed
    Score: 0.004
  196. Increased prevalence of abnormal signal-averaged electrocardiograms in older patients who have hypertension with low diastolic blood pressure. Am Heart J. 1993 Jun; 125(6):1698-703.
    View in: PubMed
    Score: 0.004
  197. Rationale for establishing a mechanism to increase reimbursement to hypertension specialists. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):397-403.
    View in: PubMed
    Score: 0.004
  198. Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):404-12.
    View in: PubMed
    Score: 0.004
  199. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol. 1992 Nov 15; 70(15):1347-52.
    View in: PubMed
    Score: 0.004
  200. Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2013 Feb; 260(2):590-6.
    View in: PubMed
    Score: 0.004
  201. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012 Oct 02; 60(14):1271-7.
    View in: PubMed
    Score: 0.004
  202. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
    View in: PubMed
    Score: 0.004
  203. Hypertension, diuretics, and coronary heart disease: a case of apples and oranges, reciprocal prejudice, and a partially-clad emperor? Am J Hypertens. 1992 Sep; 5(9):665-6.
    View in: PubMed
    Score: 0.004
  204. Influences on infant feeding decisions of first-time mothers in five European countries. Eur J Clin Nutr. 2012 Aug; 66(8):914-9.
    View in: PubMed
    Score: 0.004
  205. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21.
    View in: PubMed
    Score: 0.004
  206. Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertens. 1992 Apr; 10(4):399-400.
    View in: PubMed
    Score: 0.004
  207. Cardiovascular risk factors, clustering and complications in overweight young men. Med Sect Proc. 1992; 107-15.
    View in: PubMed
    Score: 0.004
  208. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991 Dec; 4(12 Pt 1):924-31.
    View in: PubMed
    Score: 0.004
  209. Training providers in hypertension guidelines: cost-effectiveness evaluation of a continuing medical education program in South Carolina. Am Heart J. 2011 Oct; 162(4):786-793.e1.
    View in: PubMed
    Score: 0.004
  210. Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture. Int J Obes. 1991 Sep; 15 Suppl 2:133-9.
    View in: PubMed
    Score: 0.004
  211. Popliteo-pedal bypass surgery for critical limb ischemia. Ir J Med Sci. 2011 Dec; 180(4):829-35.
    View in: PubMed
    Score: 0.004
  212. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
    View in: PubMed
    Score: 0.004
  213. Salt loads raise plasma fatty acids and lower insulin. Hypertension. 1991 Jun; 17(6 Pt 2):958-64.
    View in: PubMed
    Score: 0.004
  214. Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens. 1991 May; 4(5 Pt 1):416-21.
    View in: PubMed
    Score: 0.004
  215. Measuring the impact of a continuing medical education program on patient blood pressure. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):517-22.
    View in: PubMed
    Score: 0.004
  216. Comparative effects of overweight on cardiovascular risk in younger versus older men. Am J Cardiol. 1991 Feb 01; 67(4):248-52.
    View in: PubMed
    Score: 0.004
  217. Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr. 1991; 69 Suppl 25:45-50.
    View in: PubMed
    Score: 0.004
  218. Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011; 21(2):129-34.
    View in: PubMed
    Score: 0.004
  219. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
    View in: PubMed
    Score: 0.004
  220. Attitudes and practices of resident physicians regarding hypertension in the inpatient setting. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):698-705.
    View in: PubMed
    Score: 0.004
  221. An overview of the "Positive Action for Today's Health" (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials. 2010 Nov; 31(6):624-33.
    View in: PubMed
    Score: 0.004
  222. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
    View in: PubMed
    Score: 0.003
  223. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2010 Jul; 3(4):418-23.
    View in: PubMed
    Score: 0.003
  224. Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):32-41.
    View in: PubMed
    Score: 0.003
  225. Neurogenic mechanisms initiating essential hypertension. Am J Hypertens. 1989 Dec; 2(12 Pt 2):357S-362S.
    View in: PubMed
    Score: 0.003
  226. Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension. Am J Cardiol. 1989 Oct 01; 64(12):752-5.
    View in: PubMed
    Score: 0.003
  227. Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am J Hypertens. 1989 Jun; 2(6 Pt 1):428-34.
    View in: PubMed
    Score: 0.003
  228. The importance of hemodynamic considerations in essential hypertension. Am Heart J. 1988 Aug; 116(2 Pt 2):594-9.
    View in: PubMed
    Score: 0.003
  229. Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans. Hypertension. 1988 Aug; 12(2):199-203.
    View in: PubMed
    Score: 0.003
  230. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am J Hypertens. 1988 Jul; 1(3 Pt 3):324S-330S.
    View in: PubMed
    Score: 0.003
  231. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42.
    View in: PubMed
    Score: 0.003
  232. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
    View in: PubMed
    Score: 0.003
  233. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med. 2008 Mar-Apr; 6(2):100-6.
    View in: PubMed
    Score: 0.003
  234. Vascular structure enhances regional resistance responses in mild essential hypertension. J Hypertens. 1988 Jan; 6(1):41-8.
    View in: PubMed
    Score: 0.003
  235. Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health. 2008 Jan; 98(1):63-6.
    View in: PubMed
    Score: 0.003
  236. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987 Sep; 80(3):812-7.
    View in: PubMed
    Score: 0.003
  237. Use of statins and blood pressure. Am J Hypertens. 2007 Sep; 20(9):937-41.
    View in: PubMed
    Score: 0.003
  238. Age and race impact the association between BMI and CVD mortality in women. Public Health Rep. 2007 Jul-Aug; 122(4):507-12.
    View in: PubMed
    Score: 0.003
  239. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007 Mar 12; 167(5):502-6.
    View in: PubMed
    Score: 0.003
  240. The heart and the regulation of renin. Circulation. 1987 Jan; 75(1 Pt 2):I130-3.
    View in: PubMed
    Score: 0.003
  241. Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension? Am J Cardiol. 2006 Oct 15; 98(8):1122.
    View in: PubMed
    Score: 0.003
  242. The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):257-60.
    View in: PubMed
    Score: 0.003
  243. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
    View in: PubMed
    Score: 0.003
  244. Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res. 2006 Feb; 30(2):185-93.
    View in: PubMed
    Score: 0.003
  245. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place. 2007 Mar; 13(1):179-87.
    View in: PubMed
    Score: 0.003
  246. Management of the patient with borderline hypertension. J Cardiovasc Pharmacol. 1986; 8 Suppl 5:S103-7.
    View in: PubMed
    Score: 0.003
  247. Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther. 1985 Nov; 38(5):519-24.
    View in: PubMed
    Score: 0.003
  248. Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis. J Hypertens. 2005 Nov; 23(11):2027-31.
    View in: PubMed
    Score: 0.003
  249. Nutritional and lifestyle approaches to the prevention and management of hypertension. Compr Ther. 1985 Aug; 11(8):15-20.
    View in: PubMed
    Score: 0.002
  250. Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study. Am J Hypertens. 2005 Jul; 18(7):980-5.
    View in: PubMed
    Score: 0.002
  251. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care. 2005 Jun; 28(6):1487-9.
    View in: PubMed
    Score: 0.002
  252. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005 Jun; 329(6):276-91.
    View in: PubMed
    Score: 0.002
  253. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci. 2005 Jun; 329(6):292-305.
    View in: PubMed
    Score: 0.002
  254. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51.
    View in: PubMed
    Score: 0.002
  255. A free-ranging roundtable discussion on hypertension. J Hum Hypertens. 2005 Apr; 19(4):259-66.
    View in: PubMed
    Score: 0.002
  256. Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans. J Cardiovasc Pharmacol. 1985; 7 Suppl 6:S153-8.
    View in: PubMed
    Score: 0.002
  257. Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive. Clin Exp Hypertens A. 1985; 7(2-3):243-55.
    View in: PubMed
    Score: 0.002
  258. Role of cardiopulmonary mechanoreceptors in ADH release in normal humans. Hypertension. 1984 Nov-Dec; 6(6 Pt 1):832-6.
    View in: PubMed
    Score: 0.002
  259. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):562-8.
    View in: PubMed
    Score: 0.002
  260. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51.
    View in: PubMed
    Score: 0.002
  261. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension. 2004 Feb; 43(2):358-63.
    View in: PubMed
    Score: 0.002
  262. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol. 2003 Dec 01; 92(11):1335-9.
    View in: PubMed
    Score: 0.002
  263. Role of cardiovascular receptors on the neural regulation of renin release in normal men. Hypertension. 1983 Sep-Oct; 5(5):779-86.
    View in: PubMed
    Score: 0.002
  264. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens. 2003 May; 16(5 Pt 1):331-6.
    View in: PubMed
    Score: 0.002
  265. Borderline hypertension. Prim Care. 1983 Mar; 10(1):99-113.
    View in: PubMed
    Score: 0.002
  266. Low birth weight as a risk factor for hypertension. J Clin Hypertens (Greenwich). 2003 Mar-Apr; 5(2):133-6.
    View in: PubMed
    Score: 0.002
  267. Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension. 2002 Jan; 39(1):179-83.
    View in: PubMed
    Score: 0.002
  268. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich). 2001 Jan-Feb; 3(1):29-31.
    View in: PubMed
    Score: 0.002
  269. Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension. Hypertension. 2000 Jul; 36(1):78-82.
    View in: PubMed
    Score: 0.002
  270. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med. 2000 May 22; 160(10):1472-6.
    View in: PubMed
    Score: 0.002
  271. Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci. 1999 Dec; 318(6):357-64.
    View in: PubMed
    Score: 0.002
  272. Impact of nativity and race on "Stroke Belt" mortality. Hypertension. 1999 Jul; 34(1):57-62.
    View in: PubMed
    Score: 0.002
  273. A preliminary report of mortality patterns among foundry workers. J Environ Pathol Toxicol. 1979 May-Jun; 2(5):259-72.
    View in: PubMed
    Score: 0.002
  274. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):401-5.
    View in: PubMed
    Score: 0.002
  275. Management and outcome of acute myocardial infarction in older patients in the thrombolytic era. J Am Geriatr Soc. 1999 Mar; 47(3):291-4.
    View in: PubMed
    Score: 0.002
  276. Aldosterone in obesity. Endocr Res. 1998 Aug-Nov; 24(3-4):789-96.
    View in: PubMed
    Score: 0.002
  277. Commun-I-Care: experience in the first four years. J S C Med Assoc. 1998 Jul; 94(7):318-22.
    View in: PubMed
    Score: 0.002
  278. Strategies for cardiovascular disease prevention: importance of public and community health programs. Ethn Dis. 1998; 8(2):228-39.
    View in: PubMed
    Score: 0.001
  279. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997 Apr; 313(4):195-209.
    View in: PubMed
    Score: 0.001
  280. Differences in macronutrient selections in users and nonusers of an oral contraceptive. Am J Clin Nutr. 1997 Feb; 65(2):419-24.
    View in: PubMed
    Score: 0.001
  281. Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 1997 Jan; 10(1):68-76.
    View in: PubMed
    Score: 0.001
  282. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6.
    View in: PubMed
    Score: 0.001
  283. Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer. J Clin Oncol. 1996 May; 14(5):1617-25.
    View in: PubMed
    Score: 0.001
  284. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995 Jul; 26(1):186-92.
    View in: PubMed
    Score: 0.001
  285. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995 May; 25(5):1096-105.
    View in: PubMed
    Score: 0.001
  286. Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension. 1995 Jan; 25(1):30-6.
    View in: PubMed
    Score: 0.001
  287. Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate. Clin Pharmacol Ther. 1990 Nov; 48(5):537-43.
    View in: PubMed
    Score: 0.001
  288. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7.
    View in: PubMed
    Score: 0.001
  289. Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension. J Hypertens Suppl. 1989 Dec; 7(6):S78-9.
    View in: PubMed
    Score: 0.001
  290. Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch. J Clin Endocrinol Metab. 1989 Apr; 68(4):735-9.
    View in: PubMed
    Score: 0.001
  291. Congenital pernicious anemia: effects on growth, brain, and absorption of B12. Pediatrics. 1968 Jul; 42(1):149-56.
    View in: PubMed
    Score: 0.001
  292. Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension. Hypertension. 1987 May; 9(5):459-66.
    View in: PubMed
    Score: 0.001
  293. Decreased venous distensibility and reduced renin responsiveness in hypertension. Hypertension. 1986 Jun; 8(6 Pt 2):II36-43.
    View in: PubMed
    Score: 0.001
  294. Anger and anxiety in borderline hypertension. Psychosom Med. 1986 Mar-Apr; 48(3-4):242-8.
    View in: PubMed
    Score: 0.001
  295. Cardiopulmonary mechanoreceptors and renin release in humans. Fed Proc. 1983 Jul; 42(10):2703-8.
    View in: PubMed
    Score: 0.001
  296. Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension. 1983 Mar-Apr; 5(2 Pt 2):I184-91.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.